Blood Res.  2013 Sep;48(3):165-166. 10.5045/br.2013.48.3.165.

Fighting back against chronic myelomonocytic leukemia

• Jo DY

• KMID: 2270698
• DOI: http://doi.org/10.5045/br.2013.48.3.165

Abstract

No abstract available.

MeSH Terms

Leukemia, Myelomonocytic, Chronic

Reference

1. Onida F, Barosi G, Leone G, et al. Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups. Haematologica. 2013; 98:1344–1352. PMID: 24006407.

2. Breccia M, Voso MT, Alimena G. Chronic myelomonocytic leukemia treatment with azacitidine: what have we learned so far? Leuk Res. 2013; 37:204–205. PMID: 23174191.

3. Wijermans PW, Ruter B, Baer MR, Slack JL, Saba HI, Lubbert M. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res. 2008; 32:587–591. PMID: 17881052.

4. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002; 99:840–849. PMID: 11806985.

5. Such E, Germing U, Malcovati L, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013; 121:3005–3015. PMID: 23372164.

6. Park S, Labopin M, Yakoub-Agha I, et al. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. Eur J Haematol. 2013; 90:355–364. PMID: 23320648.

7. Sun YQ, Xu LP, Liu DH, et al. Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients. Zhonghua Xue Ye Xue Za Zhi. 2013; 34:113–116. PMID: 23611216.

8. Lim SN, Lee JH, Lee JH, et al. Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Res. 2013; 48:178–184.